JUSTIN CROFT: Open Payments
NPI 1770835522 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 53 payments from 15 companies in 2025. Trend: 2023 $1,336 · 2024 $1,125 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $145 |
| Novo Nordisk Inc | 5 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| PFIZER INC. | 4 | $85 |
| Lilly USA, LLC | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Corcept Therapeutics | 3 | $60 |
| Abbott Laboratories | 3 | $56 |
| Boston Scientific Corporation | 2 | $50 |
| Electromed, Inc. | 2 | $46 |
Products named: Kerendia, NURTEC ODT, Ozempic, MOUNJARO, UBRELVY, QULIPTA, Korlym, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
